Jazz Pharmaceuticals stock declined 11% on July 8, 2025, while the S&P 500 saw a gain of 5.3%.
1 report, 0 independent
Updated Jul 8
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Jazz Pharmaceuticals stock declined 11% on July 8, 2025, while the S&P 500 saw a gain of 5.3%.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Jazz Pharmaceuticals
Irish tax-registered pharmaceutical corporation
Related events
- The California State Teachers Retirement System has increased its stake in Jazz Pharmaceuticals.
- Jazz Pharmaceuticals guaranteed notes issued by its subsidiary, Jazz Investments I Limited, on August 26, 2026.
- Jazz Pharmaceuticals and RYTHM are competing in the pharmaceutical market and listed on the Nasdaq stock exchange.
Coverage
Newest first; wire copies grouped- Unknown outlet